RemeGen Co., Ltd. (09995)

DirectorFromToPosition(s)Release Date / Document LinksReason for Change
Babiuk Lorne Alan11-May-2001-Jun-21INED
Chen Yunjin05-May-22INED
Fang Jianmin16-Oct-08CEO, Co-Fdr
Hao Xianjing11-May-20INED
He Ruyi11-May-2006-Feb-25EDDue to personal career development, Dr. He Ruyi has tendered his resignation. He has confirmed that he has no disagreement with the Company, the Board and the management of the Company, and there is no matter relating to his resignation that needs to be brought to the attention of the shareholders of the Company.
Huang Houston Guobin10-Jan-25INED
Li Jia11-May-2004-Sep-23CFO, CoSecDue to his personal career development
Li Yupeng11-May-20Sup
Li Zhuanglin11-May-20Sup
Lin Jian04-Jul-08ED
Ma Lan01-Jun-2110-Jan-25INEDDr. Ma ceased to be an independent non-executive Director, the chairman of the Nomination Committee and a member of the Strategy Committee upon conclusion of the EGM. Dr. Ma has confirmed that she has no disagreement with the Board and that there is no other matter in relation to her resignation that needs to be brought to the attention of the Shareholders.
14-Nov-24MbNCResignation in accordance with the relevant regulations governing part-time engagement of academicians of the Chinese Academy of Sciences. Her resignation will take effect on the date on which a new independent non-executive Director is appointed and takes office.
Ren Guangke11-May-20ChSup
Su Xiaodi26-May-25MbNC
11-May-20NED
Tam Vivien Pak Yu11-May-20CoSec
Tong Shaojing28-Sep-23CFO, CoSec
Wang Liqiang11-May-20NED
Wang Weidong21-Jun-19Ch
30-Oct-13ED
26-May-25MbNCThe change was made in response to the amended Corporate Governance Code and the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, effective July 1, 2025, to strengthen the effectiveness and diversity of the Board and enhance good corporate governance practice.
Yu Shanshan11-May-2005-May-22INED